Augmedix (Nasdaq: AUGX), a leader in ambient AI medical
documentation and data solutions, today announced its go-to-market
partnership with SADA, an Insight company, a leading cloud business
and technology consultancy. The collaboration is focused on
leveraging the companies’ combined technology expertise and
expanding their reach to provide greater product and service value
to health systems seeking high-quality ambient documentation and
structured data products.
"We are thrilled to join forces with SADA, to
partner with an organization that has a nationwide reach to health
systems, and also to leverage their prowess in frontier cloud
infrastructure technology, machine learning, integrations, and
implementations,” said Ian Shakil, founder, director, and chief
strategy officer of Augmedix. “Together, we can accelerate efforts
to bring ambient medical documentation and data solutions to
benefit more patients and clinicians.”
SADA provides cloud, data, artificial
intelligence, cybersecurity, and intelligent edge solutions and
services. It is also a service partner for Google Cloud with 10
specializations, including security, infrastructure, cloud
migration, data analytics, application development, location-based
services, and machine learning. SADA offers unique expertise in
frontier Google Cloud Platform (GCP) integrations, focusing on
generative AI models, especially MedLM, a family of models
fine-tuned for healthcare industry use cases.
"SADA is proud to have provided Augmedix with
technical services for many years,” said Michael Ames, managing
director of Healthcare and Life Sciences Professional Services.
“Now, as part of Insight, we are excited to embark on a new phase
of partnership, bringing together our expertise in data and
analytics, Insight’s vast reach in the healthcare industry, and
Augmedix’s cutting-edge technology to accelerate scalable
enterprise adoption for Augmedix. Our combined entities’ reach and
capabilities will empower us to advance Augmedix’s products beyond
core charting. This partnership represents our commitment to
pushing the boundaries of what's possible in healthcare and cloud
technology."
As a Google Cloud Premier Partner across several
product and engagement models, SADA has deep engineering
capabilities across the entire Google Cloud stack and specializes
in Google Cloud priority workloads. The go-to-market partnership
enables SADA to closely work on reference architecture with Google
Cloud and Augmedix, further accelerating Augmedix’s positioning as
an innovation partner.
"Augmedix's partnership with SADA will help
bring ambient documentation to more healthcare organizations around
the country," said Amy Waldron, global director of Healthcare
Strategy & Solutions, Google Cloud. "Importantly, this work
will help improve how medical data is captured, enhancing
efficiency, and ultimately improving patient care. This
collaboration underscores our commitment to empowering
organizations like Augmedix and SADA to drive meaningful change in
the healthcare industry."
About Augmedix
Augmedix (Nasdaq: AUGX) empowers clinicians to
connect with patients by liberating them from administrative burden
through the power of ambient AI, data, and trust.
The platform transforms natural conversations
into organized medical notes, structured data, and point-of-care
notifications that enhance efficiency and clinical decision
support.
Incorporating data from millions of interactions
across all care settings, Augmedix collaborates with hospitals and
health systems to improve clinical, operational, and financial
outcomes.
Augmedix is headquartered in San Francisco, CA,
with offices around the world. To learn more, visit
www.augmedix.com.
About SADA, an Insight Company
SADA, An Insight company, is a market leader in
professional services and an award-winning solutions provider of
Google Cloud. Since 2000, SADA has been committed to helping
customers in healthcare, media, entertainment, retail,
manufacturing, and the public sector solve their most complex
challenges so they can focus on achieving their boldest ambitions.
With offices in North America, India, and Armenia providing sales
and customer support teams, SADA is positioned to meet customers
where they are in their digital transformation journey. SADA is a
6x Google Cloud Partner of the Year award winner with 10 Google
Cloud Specializations and has been recognized as a Niche Player in
the 2023 Gartner® Magic Quadrant™ for Public Cloud
IT Transformation Services. SADA has been named to Inc. Magazine’s
Best Workplaces four years in a row. Learn more at
www.sada.com.
Contact Information
Investors:Matt Chesler, CFAFNK IR646-809-2183augx@fnkir.com
investors@augmedix.com
Media:Kaila GrafemanAugmedixpr@augmedix.com
Forward-Looking Statements
This press release contains “forward-looking
statements” that involve a number of risks and uncertainties. Words
such as “believes,” “may,” “will,” “estimates,” “potential,”
“continues,” “anticipates,” “intends,” “expects,” “could,” “would,”
“projects,” “plans,” “targets,” “excited,” “optimistic,” and
variations of such words and similar expressions are intended to
identify forward-looking statements. Such forward-looking
statements include, without limitation, statements regarding the
partnership enabling Augmedix to accelerate scaling efforts for
digital health solutions and integrations that work seamlessly at
the point of care; accelerating our efforts to bring ambient
medical documentation and data solutions to benefit more patients
and clinicians; furthering Augmedix’s positioning as an innovation
partner; Augmedix's partnership with SADA and Google Cloud
representing a pivotal moment in healthcare technology; and being
poised to revolutionize how medical data is captured, enhancing
efficiency and improving patient care. Actual results could differ
materially from those stated or implied in forward-looking
statements due to a number of factors, including but not limited
to, risks detailed in our most recent Form 10-K filed with the U.S.
Securities and Exchange Commission on March 26, 2024, as well as
other documents that may be filed by us from time to time with the
U.S. Securities and Exchange Commission. The forward-looking
statements included in this press release represent our views as of
the date of this press release. We undertake no intention or
obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.
These forward-looking statements should not be relied upon as
representing our views as of any date subsequent to the date of
this press release.
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
From Aug 2023 to Aug 2024